MEDIFAST INC (NYSE:MED) — Market Cap & Net Worth
Market Cap & Net Worth: MEDIFAST INC (MED)
MEDIFAST INC (NYSE:MED) has a market capitalization of $118.38 Million ($118.38 Million) as of May 8, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #18572 globally and #4103 in its home market, demonstrating a 17.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDIFAST INC's stock price $12.69 by its total outstanding shares 10991273 (10.99 Million). Analyse MEDIFAST INC cash flow conversion to see how efficiently the company converts income to cash.
MEDIFAST INC Market Cap History: 2015 to 2026
MEDIFAST INC's market capitalization history from 2015 to 2026. Data shows change from $254.84 Million to $139.48 Million (-4.98% CAGR).
MEDIFAST INC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDIFAST INC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.32x
MEDIFAST INC's market cap is 0.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
92.62x
MEDIFAST INC's market cap is 92.62 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $254.84 Million | $272.77 Million | $20.06 Million | 0.93x | 12.71x |
| 2016 | $360.11 Million | $274.53 Million | $17.84 Million | 1.31x | 20.19x |
| 2017 | $620.58 Million | $301.56 Million | $27.72 Million | 2.06x | 22.39x |
| 2018 | $1.13 Billion | $501.00 Million | $55.79 Million | 2.26x | 20.26x |
| 2019 | $1.02 Billion | $713.67 Million | $77.92 Million | 1.43x | 13.09x |
| 2020 | $1.90 Billion | $934.84 Million | $102.86 Million | 2.03x | 18.46x |
| 2021 | $2.08 Billion | $1.53 Billion | $164.03 Million | 1.36x | 12.66x |
| 2022 | $1.20 Billion | $1.60 Billion | $143.57 Million | 0.75x | 8.35x |
| 2023 | $738.83 Million | $1.07 Billion | $99.42 Million | 0.69x | 7.43x |
| 2024 | $193.67 Million | $602.46 Million | $2.09 Million | 0.32x | 92.62x |
Competitor Companies of MED by Market Capitalization
Companies near MEDIFAST INC in the global market cap rankings as of May 8, 2026.
Key companies related to MEDIFAST INC by market ranking:
- Rollins Inc (NYSE:ROL): Ranked #1008 globally with a market cap of $26.07 Billion USD.
- Service Corporation International (NYSE:SCI): Ranked #2117 globally with a market cap of $10.92 Billion USD.
- Frontdoor Inc (NASDAQ:FTDR): Ranked #3780 globally with a market cap of $4.67 Billion USD.
- H&R Block Inc (NYSE:HRB): Ranked #4358 globally with a market cap of $3.71 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1008 | Rollins Inc | NYSE:ROL | $26.07 Billion | $54.19 |
| #2117 | Service Corporation International | NYSE:SCI | $10.92 Billion | $78.44 |
| #3780 | Frontdoor Inc | NASDAQ:FTDR | $4.67 Billion | $66.12 |
| #4358 | H&R Block Inc | NYSE:HRB | $3.71 Billion | $29.32 |
MEDIFAST INC Historical Marketcap From 2015 to 2026
Between 2015 and today, MEDIFAST INC's market cap moved from $254.84 Million to $ 139.48 Million, with a yearly change of -4.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $139.48 Million | +18.82% |
| 2025 | $117.39 Million | -39.39% |
| 2024 | $193.67 Million | -73.79% |
| 2023 | $738.83 Million | -38.34% |
| 2022 | $1.20 Billion | -42.31% |
| 2021 | $2.08 Billion | +9.36% |
| 2020 | $1.90 Billion | +86.18% |
| 2019 | $1.02 Billion | -9.73% |
| 2018 | $1.13 Billion | +82.11% |
| 2017 | $620.58 Million | +72.33% |
| 2016 | $360.11 Million | +41.31% |
| 2015 | $254.84 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of MEDIFAST INC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $118.38 Million USD |
| MoneyControl | $118.38 Million USD |
| MarketWatch | $118.38 Million USD |
| marketcap.company | $118.38 Million USD |
| Reuters | $118.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MEDIFAST INC
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. … Read more